Commitment to Action

Cancer in the Middle East - Personalized Medicine

Commitment by

King Hussein Cancer Foundation, Ghida Talal

In 2010, The King Hussein Cancer Foundation and Center (KHCF and KHCC) in Amman, Jordan committed to establish 'Personalized Medicine' as part of its efforts to provide the latest technology in combating the rising rates of cancer in the Middle East. This approach uses molecular testing methods to, allow doctors to determine with greater precision specific treatment plans in order to avoid unnecessary treatments and surgeries. Through the implementation of Personalized Medicine, KHCC aims to reduce the long-term effects of chemotherapy, radiation therapy and surgeries, improve treatment outcomes, and make strides in research specific to the Middle Eastern demographic

Share

Tabs

Overview
Summary

Commitment

Cancer in the Middle East - Personalized Medicine

Launched

2010

Est. Duration

3 Years

Estimated Total Value

$1,000,000

Region

Middle East & North Africa

Countries

IRAQ, JORDAN, LEBANON, Palestinian Territories, Syria

Commitment by

King Hussein Cancer Foundation, Ghida Talal